Cargando…
Effect of fluvoxamine on plasma interleukin-6 in patients with major depressive disorder: a prospective follow-up study
INTRODUCTION: Major depressive disorder (MDD) is associated with low-grade inflammation, and anti-inflammatory treatment can help improve depressive symptoms. A recent study found that fluvoxamine (FLV) can reduce Interleukin-6 (IL-6) production via sigma-1 receptor in inflammation models. However,...
Autores principales: | Li, Xueqin, Yan, Danfeng, Liao, Mei, Zhang, Li, Li, ZeXuan, Liu, Bangshan, Chen, Yanjun, Zhang, Yan, Liu, Jin, Li, LingJiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10247978/ https://www.ncbi.nlm.nih.gov/pubmed/37304432 http://dx.doi.org/10.3389/fpsyt.2023.1163754 |
Ejemplares similares
-
Prediction of Clinical Outcomes With EEG Microstate in Patients With Major Depressive Disorder
por: Yan, Danfeng, et al.
Publicado: (2021) -
Evidence for Progressive Cognitive Deficits in Patients With Major Depressive Disorder
por: Liu, Jin, et al.
Publicado: (2021) -
Exploration of Major Cognitive Deficits in Medication-Free Patients With Major Depressive Disorder
por: Liu, Jin, et al.
Publicado: (2019) -
State-Independent Microstructural White Matter Abnormalities in Major Depressive Disorder
por: Dong, Qiangli, et al.
Publicado: (2020) -
Gender Differences in Dysfunctional Attitudes in Major Depressive Disorder
por: Qin, Xuemei, et al.
Publicado: (2020)